Related Experiment Video
Updated: Jun 26, 2026

07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Stage migration with sentinel node biopsy in breast cancer
Rakhshanda Layeequr Rahman1, Eric Siegel, Cristiano Boneti
1Department of Surgery, Division of Breast Surgical Oncology, University of Arkansas for Medical Sciences and the Central Arkansas Veterans Hospital System, Little Rock, AR 72205, USA.
American Journal of Surgery
|January 31, 2009
Summary
Axillary staging is crucial for breast cancer prognosis. This study documents stage migration, showing lower relapse rates in patients staged with sentinel lymph node biopsy compared to axillary lymph node dissection.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Research
Background:
- Axillary lymph node status is a primary prognostic indicator in breast cancer.
- Understanding stage migration is essential for accurate breast cancer staging.
- This study retrospectively examines stage migration in breast cancer patients.
Purpose of the Study:
- To document the phenomenon of stage migration in breast cancer staging.
- To compare relapse rates between sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND).
- To evaluate the impact of SLNB and ALND on breast cancer patient outcomes.
Main Methods:
- Retrospective analysis of 392 breast cancer patients.
- Inclusion of data on sentinel lymph node identification, axillary lymph node dissection, and adjuvant treatments.
- Follow-up for disease relapse, categorized as local or systemic.
Main Results:
- Five percent of patients had sentinel lymph nodes that could not be identified, necessitating axillary lymph node dissection.
- Disease relapse occurred in 5% of patients, with earlier relapse linked to lymph node status, tumor grade, and size.
- SLNB-staged patients demonstrated lower relapse rates compared to those undergoing ALND, supporting the stage migration phenomenon.
Conclusions:
- The study confirms stage migration, where sentinel lymph node biopsy staging appears to result in lower observed relapse rates.
- This phenomenon impacts the interpretation of prognostic information derived from axillary staging.
- Accurate staging through SLNB is critical for reliable breast cancer prognosis and treatment planning.
